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Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite. It has extensive host populations and is
prevalent globally; T. gondii infection can cause a zoonotic parasitic disease. Microneme protein 3 (MIC3) is a
secreted protein that is expressed in all stages of the T. gondii life cycle. It has strong immunoreactivity and
plays an important role in the recognition, adhesion and invasion of host cells by T. gondii. This article reviews
the molecular structure of MIC3, its role in the invasion of host cells by parasites, its relationship with parasite
virulence, and its induction of immune protection to lay a solid foundation for an in-depth study of potential
diagnostic agents and vaccines for preventing toxoplasmosis.
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Background
Toxoplasma gondii (T. gondii) is an obligate intracellular
protozoan parasite (Fig. 1) [1]. It has extensive host pop-
ulations, is prevalent globally, and can cause a zoonotic
parasitic disease [2, 3]. As an opportunistic infection fac-
tor, T. gondii can cause death in patients with impaired
immune function or immune suppression, such as ac-
quired immunodeficiency syndrome (AIDS) patients,
organ transplantation patients, and malignant tumor
patients. Toxoplasmosis is also an important biological
factor influencing human prenatal and postnatal care
because if a pregnant woman is infected with T. gondii,
maternal-fetal vertical transmission may occur and re-
sult in miscarriage, stillbirth or congenital defects or
deformities (malformation, retardation, etc.) in fetus
[4]. The major hazards after T. gondii infection in animals
is the treatment cost after outbreak of toxoplasmosis and
the direct loss caused by animal death; another hazard
is the indirect loss caused by long-term parasite hosting
to become a potential infection source and cause repro-
ductive disorders [5].
T. gondii is highly evolved to form a complex, well-
coordinated system. It regulates the secretion pathway* Correspondence: wangyh061001@163.com
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motility, nutritional requirements in the intracellular
survival and replication process after invasion into hosts,
and the final release after invasion [6]. Continuous ob-
servation of the process of invasion into hosts by T.
gondii by electron microscopy showed that the invasion
of host cells by T. gondii is not similar to that of other
intracellular pathogens that require making full use of
the phagocytosis function of host cells for invasion. T.
gondii utilize an active invasion process, relying on its
energy and the “gliding motility” produced by its actin-
myosin system (Fig. 2) [7–11]. The completion of this
process depends on a series of functions by different
organelles at specific times, including microneme pro-
teins (MIC), rhoptry proteins (ROP), and dense granule
antigens (GRA) [12]. Among these, MICs secreted by
the microneme play a basic role in the recognition, ad-
hesion, and invasion of parasites into host cells during
the invasion process. At the early stage of contact be-
tween parasites and host cells, MICs are first secreted
from the apex of tachyzoites and facilitate adhesion
through the recognition of receptors on the cell mem-
brane of hosts; thus, they play an important role in the
early stage of the invasion of host cells by parasites
[13]. Currently, there are at least 19 types of known
MICs (Table 1) [14–34], including MIC1-MIC12,article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 3D reconstruction of an extracellular T. gondii tachyzoite. Reprinted from [1], Copyright ©2011, with permission from Elsevier. a–d Transversal
slices of a parasite used for reconstruction from the apical (a), b to the middle c and posterior portions of the cell body, by FIB-SEM dual beam.
a Face view of the polar ring (arrow) with micronemes (arrowhead) around it and rhoptry necks inside. b Between the polar ring and the nucleus, a
rhoptry (r) and a dense granule (dg) can be identified. c At the upper level of the nucleus (N) elements from the Golgi complex (GC) and mitochondrial
profiles (m) are seen. d Rendered model. The plasma membrane is transparent white. Inside the parasite several dense granules (blue) are scattered in
the cytoplasm, 10 rhoptries (green) and many micronemes (red) are seen around the conoid (arrow). The neck of one rhoptry is seen inside the conoid
(white arrow) [1]
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of which 10 types (TgMIC1-4, TgMIC6-9, TgMIC12,
and SPATR) contain different adhesion domains similar
to the adhesion molecules in eukaryotic cells (integrin-like
domain, thrombospondin type-1 repeat (TSR), epidermal-
growth factor (EGF)-like domain, chitin binding-like (CBL)
domain, and the Apple domain). These proteins play a
role in the process of recognition and adhesion of host
cells by parasites [6]. MIC3 can bind to the receptors of
a variety of host cells through its ligand structural do-
main; thus, it is closely associated with the invasion of
host cells by parasites and the virulence of the infec-
tion. In addition, MIC3 is expressed in the tachyzoite,
bradyzoite, and sporozoite stages and has excellent im-
mune effects. Therefore, MIC3 has received extensive
attention. This article reviews the structure and function
of MIC3, its function in the invasion of host cells by para-
sites, its association with the virulence of parasites, and its
induced immune protection.Molecular characteristics of MIC3
The length of the mic3 gene sequence is 1,080 bp; the
sequence encodes 359 amino acids and a protein with a
molecular weight of 38 kD. The mic3 gene is a single
copy gene; it does not have any introns, and there is not
a eukaryote-specific TATA or CCAAT promoter se-
quence at the 5’-end non-coding region. The complete
open reading frame defined by the first ATG codon
encodes 359 amino acids, which contain 34 cysteine
residues. There is a short hydrophobic signal peptide
sequence at the N terminus, and there is no transmem-
brane protein domain. There is 1 potential glycosylation
site and 12 phosphorylation sites. Amino acid sequence
identities of MIC3 among different Toxoplasma strains
are very high, more than 98.3 % (Fig. 3). In contrast, large
sequence differences exist among different apicomplexan
parasites (Fig. 3). MIC3 structure contains 5 partially over-
lapped EGF-like domains, of which 3 domains form a tan-
dem repeat and the other 2 domains are overlapped with
Fig. 2 Host cell invasion by T. gondii. Reprinted from [11], Copyright © 2004, with permission from Elsevier. a Schematic representation of T.
gondii tachyzoite and the subcellular structures involved in gliding motility and host cell invasion. b Cycle of host cell invasion and egress by T.
gondii. This multi-step process includes the attachment to host cells, the discharge by the micronemes (red), the discharge by the rhoptries
(yellow), the formation and sealing of the parasitophorous vacuole, intracellular parasite replication, lysis of the PVM and parasite egress [11]
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The CBL domain may be involved in protein-protein and
protein-carbohydrate interactions [18]. Cèrède et al. re-
ported that the MIC3 of T. gondii tachyzoites is a 38-kDa
(monomer) end product from the proteolytic digestion of
a 40-kDa precursor, which is then folded into a 90-kDa
dimer [35]. These specific structures are closely associated
with the function of MIC3. Amino acid mutagenesisexperiments confirmed that the formation of MIC3 di-
mers did not rely on disulfide bonds between peptides and
may be instead associated with the interaction between
proteins. The dimer is necessary for the adhesion function.
EGF-like domains are present in many proteins; they
are distributed in the extracellular region of membrane-
binding proteins or secreted proteins through a tandem
repeat form. Their function is still not completely clear.
Table 1 Properties of Toxoplasma microneme proteins
MICs MW(kDa)a Domains/homologies Major putative functions References
MIC1 49 2 TSRs Transport/folding of MIC4 and MIC6 [14, 15]
Binding to host cells
MIC2 83 1 Integrin, 5 TSRs, and 1 TM Transport M2AP and adhesion [16, 17]
MIC3 38(90 dimer) 1 CBL and 5 EGF Adhesion [14, 18]
MIC4 63 6 Apples Adhesion [19, 20]
MIC5 20 Parvulin-like PPIase motif Suppressing TgSUB1 activity [21]
MIC6 37 3 EGF-like Escorter [20]
MIC7 36 5 EGF-like and 1 TM unkown [13]
MIC8 75 1 CBL, 10 EGF-like, and 1 TM Escorter [13]
MIC9 32 3 EGF and 1 TM unkown [13]
MIC10 23 unkown [22]
MIC11 22 unkown [23]
MIC12 234 31 EGF, 4 TSRs, and 1 TM unkown [24]
AMA1 60 Cysteine rich Inhibiting secretion of the rhoptries [25]
M2AP 35 Beta and coil Transport/folding of MIC2 [26, 27]
SUB1 85 Subtilase and GPI Proteolysis [28]
ROM1 28 Rhomboid Proteolysis [29, 30]
SPATR 47.5b 1 thrombomodulin EGF, 2 TSRs Trafficking of the protein [31]
PLP1 124 Cytolysis and parasite egress [32, 33]
TLN4 256 unkown [34]
aBased on the complete open reading frame including signal sequence or GPI anchor signal; bPredicted molecular weight (MW) after removal of the
signal peptide
Abbreviation: TM transmembrane
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receptors of host cells through the EGF-like domain, ad-
hesion experiments were conducted between MIC3 and
cells. The experimental results showed that regardless of
whether cells had EGF-like receptors, there were no differ-
ences among the adhesion results. This finding indicates
that the EGF-like domain was either not involved in adhe-
sion between MIC3 and cells or that the EGF-like domain
did not interact with the EGF-like receptors in host cells.
Through the expression of different MIC3 fragments on
the surface of host cells, it was elucidated that the CBL
domain was necessary for the adhesion characteristics
of MIC3. In contrast, the EGF-like domain could not
promote adhesion of parasite MIC3 to host cells but
may enable the accurate presentation of the adhesion
structure from the structure formation aspect.
The MIC3 complex of T. gondii
During the process of secretion, transport, and release,
MICs interact with other MICs to function in a complex
form. Currently, the known MIC complexes include the
MIC1/4/6 complex, MIC3/8 complex, MIC2/M2AP com-
plex and AMA1/RON2/RON4/RON5/RON8. At least one
protein in the complex contains a transmembrane domain
and a cytoplasmic tail. The cytoplasmic tail contains asorting signal. The sorting signal is necessary for trans-
porting the complex from the endoplasmic reticulum (ER)
to the relevant locations in the micronemes; thus, this pro-
tein is defined as an “escorter” [13, 20] and is called a
transmembrane protein. MIC8 is the escorter of the
MIC3/8 complex (Fig. 5) [13]. MIC3 reaches micronemes
under the escort of its escorter, MIC8. It is discharged out-
side parasites during the process of invasion of the host
cell by parasites and is then re-localized on the surface of
the host cells (Fig. 6) [18]. Proteins that interact with
escorters are soluble proteins. The normal execution of
transmembrane protein functions also depends on its
interacting soluble proteins. Only following an interaction
between soluble proteins and transmembrane proteins can
they be correctly folded to form a complex with biological
functions; otherwise, the function of the complex will be
damaged. For example, following disruption of the mic1
gene of T. gondii, its partner proteins, MIC6 and MIC4,
remained in the Golgi apparatus [20]; when the m2ap
gene of T. gondii was knocked out, MIC2 was retained
and accumulated in the Golgi apparatus, thus causing a
significant decrease in MIC expression levels [27]. Al-
though the interactions between proteins are very import-
ant, there are some exceptions. For example, after the
mic3 gene of T gondii was knocked out, the transport of
Fig. 3 Amino acid sequence alignment of MIC3 from apicomplexan
parasites. Toxoplasma MIC3 (AF509564.1: RH.SSI strain; AJ132530.1: RH.ERP
strain; EU572718.1 GJS strain; JF330835.1 RH strain, and XM_002369792.1:
ME49 strain), Neospora caninum (XM_003880575.1: Liverpool strain),
Hamondia Hammond MIC3 (XM_008886980.1: H.H.34 strain), and
Eimeria tenella (FJ374765.1: Houghton strain). Amino acid sequence
alignment was generated by MegAlign. Identical amino acid
residues are colored in blue
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micronemes were not affected [14]. These stable com-
plexes better explain how soluble proteins are sorted after
regulation and secretion and how soluble adhesins assist
the invasion process [36, 37]. However, whether the func-
tions of these complexes in the motility and cell invasion
processes of T. gondii are repeated or redundant are still
unknown [14, 25].
Regulatory mechanisms of MIC secretion
Micronemes are secretion organs that are located at the
apical ends of parasites. MICs are synthesized at the
rough ER, are transported to micronemes through the
Golgi apparatus and are secreted outside the body. It is
generally accepted that the secretion of T. gondii MICs
is only regulated by the intracellular calcium ion levels
in parasites [38]. Under normal conditions, T. gondii
tachyzoites secret MICs at a very low level; when the
intracellular calcium ion level increases, the secretion of
MICs can increase 10-100-fold [39]. The imbalance of
calcium ions will induce the deregulation of MIC secretion.
Some reagents that can neutralize intracellular calcium ions
can strongly inhibit MIC secretion by micronemes. The
regulation of MIC secretion by calcium ions in parasites
does not require the participation of exogenous calcium
ions [40, 41]. Additionally, through the research of micro-
neme secretion based on levels of MIC5, Carey et al. ex-
trapolated that there could be two types of micronemes:
one that discharges rapidly in response to elevated intracel-
lular calcium, and one that discharges constitutively [42].
Further larger trials are needed to determine whether two
types of micronemes exist.
MIC3 protein folding and hydrolysis
Newly synthesized proteins require structural modifica-
tion at the ER. Misfolded or incompletely folded oligo-
meric complexes will be retained at the ER and will
finally be degraded. There are some molecular chaper-
ones and folding enzymes at the ER; they can assist the
correct folding and assembly of proteins and can provide
anchor points for retained immature proteins [43]. The
retention functions of ER rely on different folding sen-
sors; the N-glycans on the surface of misfolded proteins
can be recognized by calreticulin and calnexin. The ex-
posed cysteine residue plays a role in thiol-mediated
Fig. 4 Schematic drawing of the MIC3 constructs. EGF domains II, III, and IV are tandemly repeated. EGF domains I and V overlap with other domains
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tase on the ER membrane is associated with the retention
of unassembled proteins. MIC3, MIC4, and MIC6 are rich
in cysteine residues [35]. When the early peptides are
transported to the ER, cysteine residues form disulfide
conjugates to perform correct folding. Incorrectly folded
proteins may form aggregates and cannot be correctly
transported.
The hydrolysis processing of MICs is very common and
is necessary for the smooth completion of the invasion
process, which mainly occurs in 2 stages. The first stage
occurs at the secretory pathway, that is, transportation
to the micronemes through the Golgi apparatus after
synthesis by the rough ER. The hydrolysis process at
this stage is associated with the formation of specific
complexes, correct targeting of complexes to organelles,
and masking of enzyme active sites. MIC3, MIC5, MIC6,
and M2AP are actively involved in this stage [20, 44]. The
second stage occurs after extracellular secretion and dis-
charge during the process of the invasion of host cells by
T. gondii. The processing at the second stage is helpful
for the completion of complex separation, host cellFig. 5 MIC8 serves as escorter for the non-membrane adhesin TgMIC3. Repri
IFA analysis by confocal microscopy of parasites transiently transfected with p
the plasma membrane of the parasites. TgMIC3 redistributed to the plasma m
perfectly sorted to the micronemes in a vacuole containing non-transfected padhesion, and invasion of parasites. For example, the
protein processing of MIC2, MIC4, MIC6, and MIC8
induce the rapid release of MICs on the cell surface,
which is a key step for completion of the cell invasion.
If processing is lacking, secreted MICs can establish
persistent, stable bridges on the surface of host cells and
parasites, thus interfering with the newly formed correct
closure of parasitic vesicles and inhibiting the proliferation
of parasites in vacuoles. Studies showed that unprocessed
MICs increased adhesion to host cells; however, the in-
vaded parasites decreased. Many MICs are produced as a
pre-protein form and go through proteolytic processing
during the secretion pathway and transport process. When
crossing the Golgi apparatus, the first EGF-like domain
of MIC6 is removed [13]; the function of this process is
unknown, but this step does not affect the microneme
targeting ability of the interaction between MIC6 and
MIC1 [20]. MIC3 is also initially synthesized as a 40-
kDa dimeric precursor, which then becomes a 38-kDa
product through proteolysis before reaching the micro-
nemes [45]. The removal of the leader peptides of MICs
is necessary for interaction with the host cells [46]. Thented from [13], Copyright © 2002, with permission from Elsevier. Double
TMIC8GPI. TgMIC8 covalently linked to a GPI anchor localized perfectly at
embrane in the transiently transfected parasites, while the protein is
arasites [13]
Fig. 6 Immunofluorescence localization of MIC3 (green) and ROP1 (red) during invasion of HFF cells. Reprinted from [18], Copyright © 2000, with
permission from John Wiley and Sons. a, b, c and d are successive steps of invasion [18]
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completely clarified.
The function of MIC3 in the process of invasion of the
host cells by parasites
T. gondii can invade almost all nucleated cells, indicating
that there are multiple “receptor-ligand” interactions be-
tween parasites and host cells. Although the mechanisms
underlying the invasion of host cells by T. gondii have
not been completely clarified, current studies indicate
that T. gondii actively invades cells, unlike the endocyto-
sis processes of infection used by bacteria and viruses.
When T. gondii contacts host cells, parasites first push
the conoid outside the body, and then, micronemes dis-
charge a large amount of MICs through the conoid.
MICs interact with corresponding receptors on the host
cell membrane and are distributed on the surface of par-
asites. The front end of parasites, which interacts with
cells, forms a moving junction [47]; next, the actin-myosin
system exerts its function. At the moving junction of para-
sites, MICs move from the front end of parasites to the
rear end of parasites through the force produced by actin
proteins and are finally hydrolyzed; parasites invade cells
through the moving junctions [8, 11, 35, 47, 48]. There-
fore, MICs, including MIC3, play a bridging role between
parasites and host cells.
It has been shown that mic1 knockout alone affected
the invasion of HFF cells by T. gondii and that mic3
knockout alone did not affect the invasion; the results of
a mic3/mic1 double knockout did not show significant
differences from the mic1 knockout. These results indi-
cate that these 2 proteins did not have synergistic effects
on T. gondii invasion [49]. These results contradict those
showing that MIC3 was secreted outside cells during the
invasion process of T. gondii and adhered to a variety of
cells, including fibroblasts, macrophages, and epithelialcells. Cérède et al. [14] proposed that MICs may contain
a large number of components and that different compo-
nents could recognize the same receptor. For example,
during the infection of HFF cells after mic3 knockout,
other MICs would interact with the cell surface receptors;
however, MIC3 may be indispensable for the infection of
other cell types. In addition, during the invasion process,
parasites may have alternative invasion routes. Further-
more, in vitro culture and natural infection methods may
display differences; in in vitro culture, the disappearance
of one gene function may be compensated for by other
MICs or may up-reregulate the secretion of other MICs to
allow for normal invasion; however, this gene may be very
important in natural infection conditions.
The association between MIC3 and the virulence of parasites
MICs contain a series of conserved adhesion domains,
and some domains have been confirmed to be associated
with parasite invasion [14]. Following infection of HFF
cells after the T. gondii mic3 gene was knocked out, the
adhesion characteristics were not affected, but the para-
site virulence significantly reduced. T. gondii with gene
disruption of mic1 or mic3 were inoculated into mice,
and all of the inoculated mice died after 9–22 days of in-
oculation; mice in the control group without gene
knockout all died within 7–10 days. These results indi-
cated that after T. gondii mic1 and mic3 were separately
knocked out, the virulence of T. gondii only decreased
slightly. T. gondii with both the mic1 and mic3 genes
knocked out were inoculated into mice, and the results
showed that only 1 mouse among the 10 mice died and
that the death time of mouse was delayed by 10 days com-
pared to that of the control group. In addition, the dose
was adjusted and inoculated into mice to cause the death
of all mice on day 9; comparison of lethal doses with the
control group showed that the inoculation amount of the
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and that the dose in the control group was lower than 20
parasite/mouse. These results indicate that knockout of the
mic1 and mic3 genes together significantly reduced the
parasite virulence and confirmed that MIC1 and MIC3
had synergistic effects on the parasite virulence [14].
MIC3 has a very strong affinity for host cells, which is
closely associated with its CBL domain [35]. The com-
mon sequences of CBL domain contain 8 disulfide
bond-linked cysteine residues and several highly con-
served aromatic residues. BHK-21 cells were transfected
with the recombinant MIC3 plasmid, and the location of
the expression product was detected. The results showed
that the expression product of the recombinant MIC3
with CBL domain knockout was in the supernatant,
whereas the expression product of the recombinant
MIC3 without CBL domain knockout was on the cell
surface. These results indicate that the CBL domain of
T. gondii MIC3 is very important for cell adhesion.
In CBL domain, Cysteines determine the protein con-
formation, and aromatic residues react with N-acetylgluco-
samine. Transfection of BHK-21 cells with the recombinant
MIC3 plasmid in which all the cysteine residues in CBL
domain were replaced by glycine residues resulted in insuf-
ficient secretion and accumulation of the expression prod-
uct, indicating that cysteine residues determine the protein
conformation. In the aromatic residue replacement experi-
ment, the F121A and Y141A mutants influenced the pro-
tein expression in BHK-21 cells; however, the adhesion
characteristics of these two residues could not be con-
firmed. The transfection experiments of the other recombi-
nants (Y96A, F97A, P103A, W126A, F128A, and Y135A)
proved that only the expression products of the W126A
and F128A mutants were in the supernatant and did not
bind to the surface of transfected BHK-21 cells, indicating
that the replacement of W126 or F128 alone resulted in the
complete loss of adhesion function and that they were
closely associated with the interaction with cell surface re-
ceptors and adhesion. The replacement of tryptophan at
position 126 with glycine (W126A) and the replacement of
phenylalanine at position 128 with glycine (F128A) in the
CBL domain of MIC3 caused a significant reduction of
virulence of the mutant strains. These studies indicated that
the MIC3 CBL domain that is associated with adhesion is
very important for the virulence of parasites [14].
Induction of immune protection by MIC3
MIC3 plays important roles in the invasion process of T.
gondii; it has very strong immunogenicity and can stimulate
the production of corresponding humoral immunity and
cellular immunity in the body. Therefore, in studies of vac-
cines against T. gondii infection, MICs have received much
attention. Vaccines based on MIC3 include live attenuated
vaccines, subunit vaccines, and DNA vaccines.Gene deletion attenuated vaccine based on MIC3 of T.
gondii
Some scholars have performed studies on live attenuated
vaccines by knocking out double virulence genes of par-
asites. A mutant strain of T. gondii (RH strain) lacking
the mic1 and mic3 genes (Mic1-3KO) tachyzoites to
immunize mice and that showed mice could produce a
strong protective function [14, 49]; not only could the
mother defend against T. gondii infection but also verti-
cal transmission could be effectively prevented [49]. Of
note, the MIC1-3KO attenuated strain induced good im-
mune effects in murine models and also had ideal immune
effects in large animal models. Subcutaneously immunized
ewes with MIC1-3KO tachyzoites showed that IgG anti-
bodies occurred in serum samples. Ewes at mid-gestation
were challenged with the PRU strain of T. gondii, and the
results showed that pregnant ewes in the vaccinated group
only had a slight febrile response, whereas unvaccinated
ewes produced a more severe, characteristic febrile re-
sponse of a longer duration; all unvaccinated ewes
aborted. The survival rates of newborn lambs in the
vaccinated group were 62 %, 91 %, and 64 %, and there
were no clinical signs of infection. A dose of 105
MIC1-3KO tachyzoites was sufficient to induce protective
immune responses and had very good preventive function
against toxoplasmosis-induced abortion in ewes [50]. At
present the strain MIC1-3KO is the main product of a
French innovative company (VitamFero SA) and it is
called "Toxo KO" vaccine. "Toxo KO" vaccine represents a
new generation of live and attenuated vaccines obtained
through the deletion of 2 genes of virulence, and the risk
of reversion to virulence is totally eliminated (http://
www.vitamfero.com/en/technology.html). "Toxo KO" vac-
cine will play an important role in preventing ovine and
feline toxoplasmosis.
Subunit vaccines based on MIC3 of T. gondii
Subunit vaccines are vaccines developed using DNA re-
combinant technology to introduce antigenic genes of
pathogens into prokaryotic or eukaryotic expression sys-
tems to express the corresponding antigenic proteins;
these vaccines have the advantages of easy preparation
of antigenic proteins and high yields. Nie et al. [51] vac-
cinated BALB/c mice with recombinant pseudorabies
virus (PRV) expressing MIC3 (rPRV-MIC3), and the re-
sults showed that rPRV-MIC3 could induce significant
humoral and Th1 cellular immune responses. After be-
ing challenged by the T. gondii RH strain at a lethal dose
(100 tachyzoites), the survival rate of immunized mice
was 50 %, and no protection was found in control
groups. These results indicated that rMIC3 had better
immunogenicity and could produce a certain protective
immunity, which provided reliable bases for the develop-
ment of MIC3 subunit vaccines for T. gondii. However,
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cient immunogenicity and protective function and too
short of a persistent time of the immune responses.
Nucleic acid vaccines based on MIC3 of T. gondii
T. gondii belongs to strictly intracellular parasitic protozoa.
In induced immune responses in the body, cellular immun-
ity is more important than humoral immunity; especially in
the acute infection phase, cellular immunity usually plays a
decisive role. DNA vaccines express corresponding anti-
genic proteins in host cells and comprehensively induce
specific immune responses in the body. Compared to other
vaccines, DNA vaccines have the potential advantages of
safety, stability, convenience, high efficiency, and persistent
immunity. Ismael et al. used the pMIC3i plasmid encoding
the immature MIC3 protein to intramuscularly inoculate
CBA/J mice. Immunized mice all produced high titers of
IgG2a type anti-MIC3 immunoglobulin as well as IFN-γ
and IL-2. Inoculation of mice with the pGM-CSF plasmid
encoding the granulocyte-macrophage colony-stimulating
factor gene and the pMIC3i plasmid together showed that
immunized mice produced stronger humoral immune re-
sponses. Oral administration of cysts of the 76 K strain of
T. gondii into immunized mice showed that the number of
cysts detected in the brain was significantly lower than that
in control mice [52]. Fang et al. [53] used the “suicidal”
pSCA1 vector to construct a T. gondii suicidal DNA
vaccine pSCA/MIC3. As conventional DNA vaccine
pcDNA/MIC3, suicidal DNA vaccine pSCA/MIC3 also
provides favourable efficacy. Meantime, based on the
alphavirus replicon, suicidal DNA vaccines leads even-
tually to apoptosis of the transfected cells, which is
particularly important in alleviating the concerns of
potential integration and cell transformation generated by
the use of conventional DNA vaccines, so it could improve
safety of the conventional DNA vector. In this case, the
design of vaccines against T. gondii based on suicidal
DNA approach is feasible and effective. CD4 and CD8 T
cells are the major effectors of the MIC3 DNA vaccine-
induced protection [54, 55], both Lectin-like and EGF-like
domains of MIC3 conferred protection [54]. Of note, the
MIC3 DNA vaccine induced good immune effects in large
animal models (sheep) [56].
Although monovalent DNA vaccines can induce a very
strong immune reaction in the body against T. gondii in-
fection, the preventive function is not comprehensive,
and the immune effect is not ideal [57]. Hence, in the
course of researching T. gondii vaccines, a consensus to
develop multivalent vaccines that contain a combination
of several antigens and target different developmental
stages has been reached with the aim of overcoming the
drawback of the monovalent candidate vaccines [58]. Qu
et al. [59] immunized mice with the constructed composite
DNA vaccine ZJ111/PSAG1-MIC3, and the results showedthat mice could reduce stronger humoral and Th1-type
cellular immunity than those in the control group (pSAG1,
pMIC3, and pcDNA3.1). After being challenged by the T.
gondii RH strain at a lethal dose for 12 days, the survival
rate of mice was still above 20 %, whereas mice in the con-
trol group all died within 5–6 days. Therefore, compared to
monovalent DNA vaccines, multivalent composite DNA
vaccines can produce better protective immunity. Some
other studies also support the view that the introduction of
multiantigenic DNA vaccine is more powerful and efficient
than single-gene vaccine, and deserves further evalu-
ation and development [60, 61]. The multiantigenic
DNA immunization might be an important approach to
achieve an effective vaccine against T. gondii.
Cytokines are excellent adjuvants and can significantly
enhance the immune effects of gene vaccines. IFN-γ is
an immune upregulation factor that plays a leading role.
During the process of resisting T. gondii infection by im-
mune cell, IFN-γ plays an important immune regulation
role [62]. The pcMIC3 eukaryotic expression plasmid
encoding the T. gondii MIC3 and the pcIFN-γ eukaryotic
expression plasmid encoding IFN-γ were mixed together
at 100 μg each and were then intramuscularly injected
into BALB/c mice 3 times at intervals of 2 weeks. The
results showed that mice could effectively defend the
challenge of a small dose of a strong virulent strain
of T. gondii, indicating that the recombinant plasmids
encoding the T. gondii MIC3 and IFN-γ had excellent
immunogenicity to induce strong humoral immunity
and cellular immunity [63]. Collectively, these results
demonstrated that MIC3 is considered a very promising
candidate molecule for the development of vaccines
against toxoplasmosis.
Taken together, studies have indicated that immune
protection of MIC3 is influenced by multiple factors.
Adjuvants play an important role in the efficacy of im-
munizations. It is the general consensus of opinion that
a type-1 response, particularly associated with CD8+ T
cells producing IFN-γ, is the major mediator of immun-
ity against T. gondii infection. Other important factors
in immunization experiments are the selection of animal
model (species/strain) and the selection of T. gondii
strain. In general, as mice are normally susceptible to T.
gondii infection, parasite strains with low virulence or
low doses of virulent strains may be preferentially selected
by some researchers [64]. In some studies of immunization,
oral challenges were made with cystogenic strains [65]. It is
important to point out that unnatural routes of infection
may be key determinants of mouse survival.
Studies on diagnostic reagents based on MIC3 of T. gondii
MIC3 is expressed at all stages of the life cycle of T. gondii.
Therefore, MIC3 is not only an important candidate mol-
ecule for vaccines but also a very promising candidate
Wang and Yin Parasites & Vectors  (2015) 8:384 Page 10 of 12molecule for the diagnosis of toxoplasmosis. Immuno-
logical diagnostic methods based on MIC3 of T. gondii in-
clude the indirect fluorescent antibody test (IFAT), latex
agglutination test (LAT), enzyme-linked immunosorbent
assay (ELISA), polymerase chain reaction (PCR), and so
on. Jiang et al. [66] used recombinant T. gondii MIC3
(rMIC3) as an antigen to establish a LAT; there was no
cross-reactivity with the standard positive sera of other
pathogens, such as classical swine fever virus and foot and
mouth disease virus, but there was a strong agglutination
reaction with T. gondii antibody-positive serum samples
from pigs. In addition, compared to the ELISA method
using rSAG1 as the antigen, the coincidence rate of sera
that tested positive using these two methods was 92.8 %,
and this LAT could detect specific T. gondii antibodies in
all experimental piglets infected with T. gondii tachyzoites
at 8 to 42 days after infection. Beghetto et al. [67] used
rMIC3 as an antigen to establish an immunoglobulin G
avidity assay, and this assay could detect low-avidity IgG
antibodies exclusively in sera collected within 2 months
after primary infection. The presence of low-avidity IgG
antibodies against rMIC3 antigen can be used to deter-
mine the point of infection with T. gondii within a 2-
month time frame after infection. Furthermore, another
research group also demonstrated that particular peptides
from MIC3 (MIC3–282:GVEVTLAEKCEKEFGI; MIC3–
191:SKRGNAKCGPNGTCIV) were recognized with a
significantly higher intensity by sera from acutely infected
patients than by sera from latently infected patients, and
that these peptides may be candidates for a promising
peptide panel for the diagnosis of acute toxoplasmosis in
humans [68]. These results indicated that MIC3 is a very
good marker for diagnosing recently acquired infections
and has potential clinical usefulness for diagnosing the
acute phase of T. gondii infection during pregnancy. Fur-
thermore, the mic3 gene is also a target for molecular
diagnosis of toxoplasmosis. Du et al. [69, 70] used the
T. gondii mic3 gene as a target gene to design specific
primers to establish a loop-mediated isothermal amplifica-
tion (LAMP) assay to detect T. gondii in soil. This method
had high sensitivity and could detect 5T. gondii oocysts in
0.5 g of soil, providing a rapid, sensitive, and specific mo-
lecular detection method for diagnosis of toxoplasmosis.
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Conclusions
MIC3 is a very important protein adhesion factor se-
creted by T. gondii that is expressed at the tachyzoite,
bradyzoite, and sporozoite stages. It is closely associ-
ated with the interaction with host cells and parasites,plays important roles in the early stage of host cell
invasion by parasites and is a highly promising candi-
date factor for vaccine development and diagnosis of
toxoplasmosis. Currently, studies on MICs have made
great progress, and their structures and functions are
becoming clear. The EGF-like domain of MIC3 may
have protein adhesion and signal recognition functions
during the process of invasion of host cells by T. gondii.
The correct folding, proteolysis, and expression time of
these domains also strictly affect the function of MIC3 in
parasites. Therefore, the use of methods such as bio-
informatics analysis, fluorescence labeling, establishment of
overexpression parasites, gene knockout, gene chips, and
high-throughput genome sequencing to study the functions
of MIC3 may yield further breakthroughs in parasite-host
interaction, signal recognition, and new functions of MIC3.
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